mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.8 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.8 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.8 |